SARS-CoV-2, the virus responsible for COVID-19 ... In vitro experiments with human lung-derived Calu-3 cells showed clear efficacy against multiple variants (WT, alpha, delta, and omicron BA.5) , ...

Following viral challenge with SARS-CoV-2 XBB.1.5, lung tissue samples were collected three days post-infection to quantify viral ribonucleic acid (RNA) load using quantitative reverse ...

followed by nasal inoculation with 50µl SARS-CoV-2 virus at a dosage of 10 5.5 TCID50/mL (created using BioRender.com). IB was used to detect the expression of MARCHF7 or UBR5 in the lung tissues (B).

Left lung lobe was stored in 4% PFA (v/v ... according to the manufacturer’s instructions. Genomic copies of SARS-CoV-2 Nucleocapsid (N) gene were measured as previously described (22). Briefly, ...

These data suggest that SARS-CoV-2 increases susceptibility and pathogenicity to bacterial coinfection, and further studies are needed to understand and combat disease associated with bacterial ...

Lung auscultation revealed bibasilar crackles and cardiac examination ... in the setting of his elevated D-dimer (2.40 μg/mL; RR ≤0.52) and concern for SARS-CoV-2-induced thrombophilia. On day 2, ...

Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...